Perfect Medical spruces up profits with cost-cutting makeover

The provider of medical aesthetics has flagged up a big jump in profit on the back of an efficiency drive, but the real test would be a recovery in revenue

Key Takeaways:

• Perfect Medical projected its first-half profits would rise 50% to 55%, driving a rally in its share price
• But the firm provided no revenue forecasts, leaving questions about the strength of demand in its core Hong Kong market

By Lee Shih Ta

A corporate revamp at Perfect Medical Health Management Limited (1830.HK) is starting to show results, boosting the appeal of its share price.

In a positive earnings alert on Nov. 9, the provider of medical aesthetic services projected a rise of at least 50% in its half-year profits after moves to streamline its service centers, workforce and marketing activities.

News that the efficiency drive was paying off boosted the stock towards a 52-week high, although Perfect Health did not provide revenue forecasts that would shed more light on its underlying business.

Profit for the six months to the end of September was estimated to range from HK$142 million to HK$147 million ($18.10 million to US$18.74 million), translating into a year-on-year rise of 50% to 55%. The result would reverse a year-earlier profit decline and edge the bottom line above the HK$140.8 million for the same period in 2024. The figures suggest operational changes are bearing fruit after a slowdown in demand. If revenue stabilizes, a leaner cost structure could allow a bigger part of any sales increase to flow through to profit.

Investors welcomed news of a profit uplift, sending Perfect Medical shares up 24.17% to HK$1.49 in the first trading session after the earnings alert.

Perfect Medical operates through a network of service centers, providing personalized care using equipment from Europe, the United States, Japan and South Korea. Repeat visits and the efficient deployment of therapists, equipment and facilities are key factors in its competitiveness, as handling increased volume through its established network would spread fixed costs across more services.

The company is also diversifying its brands and services to broaden its customer base and create cross-selling opportunities. Alongside its Perfect Medical and New Beauty brands, the group works with South Korean medical aesthetics provider Oracle to attract younger consumers, while offering solutions for pain management, snoring and sleep issues in a broader suite of treatments.

The company attributed its profit increase to workflow streamlining, increased digitization, consolidation within its network and improved business in Australia, Singapore and Macao. By consolidating its less productive centers, the firm can reduce idle capacity and overlapping outlays. Meanwhile, membership data and targeted marketing can help attract new customers and generate repeat purchases.

Demand still uncertain

The impact of cost-cutting was already evident in the same period of 2025, when spending on employee benefits fell 23.1%, marketing outlays dropped 29.3% and rental and lease-related expenses declined 9.8%. Measures included aligning staffing with customer traffic, eliminating ineffective promotions and renegotiating rents. Revenue nevertheless fell 21.7% and net profit sank 32.7%, as the savings were not enough to offset weaker demand.

For the fiscal year ended March 2026, revenue fell 14.7% to HK$962 million, while profit attributable to shareholders was down 13.6% at HK$179 million. The profit recovery projected for the latest six-month period has raised hopes that revenue could follow, easing persistent cost pressures.

While employee expenses fell from 36.3% to 34.7% of revenue in the last fiscal year, rental and lease-related expenses rose from 13.1% to 13.7%. A sales recovery would allow those costs to be diluted, but the profit alert provided no figures for revenue, customer traffic or same-store sales, leaving the state of demand to be confirmed in the formal results.

Hong Kong is central to that test, contributing nearly 80% of group turnover. Income there fell from HK$894 million to HK$766 million in the last fiscal year, accounting for about three-quarters of the group’s total drop in revenue. The geographic concentration makes it easier to deploy resources but also leaves results more exposed to changes in local demand. While improved operations in Australia, Singapore and Macao can help cushion earnings, a revenue turnaround hinges on more stable business in its largest market.

Perfect Medical trades at a price-to-earnings ratio of about 10.5, slightly below the 11.8 for health platform Beauty Farm (2373.HK). Acquisitions have supported Beauty Farm’s revenue growth, while Perfect Medical has relied mainly on operational tweaks to restore profit momentum. A rise in its valuation may require a stronger improvement in the top line.

Dividends are another attraction, as the company has maintained a policy of paying out 100% of its profits to shareholders for more than a decade, with a trailing dividend yield of about 9.8% in the last fiscal year. Operating cash flow of around HK$339 million over the same period also supported distributions. However, the dividend per share has fallen by more than half from two years earlier. Future payouts will still depend on a sufficient pool of earnings and cash after spending on leases and equipment.

While the company may be of interest to income-focused investors, a more than 20% surge in its share price has narrowed the valuation discount. It may be more prudent to wait for Hong Kong revenue to stabilize or for a more attractive entry price before making an investment move.

To subscribe to Bamboo Works weekly free newsletter, click here